Last updated on December 2018

Substance Misuse To Psychiatric Disorders for Cannabis


Brief description of study

With the recent availability of vortioxetine, and the surging phenomenon of cannabis misuses amongst young abusers, it is a timely opportunity to conduct an early pharmacotherapy intervention study to offer an evidence-based strategy aiming to stop individuals with cannabis use disorders with depressive or anxiety symptoms, to develop into a more chronic disabling dependence or co-morbid state.

Clinical Study Identifier: NCT03485274

Find a site near you

Start Over

Queen Mary Hospital

Hong Kong, Hong Kong
  Connect »